Description
Novoparin Solution for Injections 40 mg Syringe 0.4 ml №2
Ingredients:
Novoparin solution for injections contains 40 mg of enoxaparin sodium per 0.4 ml syringe. Enoxaparin sodium is classified as a low molecular weight heparin.
Dosage:
The recommended dosage of Novoparin solution for injections is individualized based on the patient’s condition, weight, and other factors. Typically, it is given subcutaneously once or twice daily.
Indications:
- Prevention of deep vein thrombosis (DVT) in surgical patients, especially those undergoing orthopedic procedures like hip or knee replacement.
- Treatment of DVT and pulmonary embolism.
Contraindications:
- Active major bleeding.
- Hypersensitivity to enoxaparin sodium.
- History of heparin-induced thrombocytopenia.
Directions:
Administer Novoparin solution for injections as directed by a healthcare professional. Rotate injection sites and avoid areas with bruising or scars during subcutaneous administration.
Scientific Evidence:
Enoxaparin has demonstrated efficacy in preventing and treating thrombotic events. Studies have shown its effectiveness in reducing DVT risk post-orthopedic surgery, as published in the Journal of Thrombosis and Haemostasis.
Additional Information:
- Monitor for signs of bleeding and report any unusual bleeding or bruising to a healthcare provider.
- Store Novoparin solution at room temperature, protected from light.
Pharmacological Effects: Enoxaparin inhibits specific clotting factors, preventing blood clot formation. It offers a more predictable anticoagulant response compared to unfractionated heparin.
Clinical Trials: Clinical studies have shown enoxaparin’s effectiveness in preventing DVT with a lower risk of heparin-induced thrombocytopenia. Research in the New England Journal of Medicine indicated reduced recurrent thromboembolism in acute coronary syndrome patients treated with enoxaparin.
